Literature DB >> 17917047

Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection.

Savita Pahwa1.   

Abstract

Many cytokines that utilize the common gamma (Cgamma) chain signaling pathway, viz Interleukin (IL)-2, IL-15, and IL-7 are known to be important for inducing T cell maturation, proliferation, or survival. Untreated chronic HIV infection is associated with profound quantitative and qualitative deficiency of CD4 T cells, which is partially reversed following highly active antiretroviral therapy (HAART). A subset of patients, however, fail to recover CD4 T cells despite virologic suppression. The role of Cgamma chain cytokines in influencing immune reconstitution following potent antiretroviral therapy is discussed. Maturation markers (naïve, central memory, effector memory, and effector), cytokine receptors IL-2Rbeta, Cgamma chain, IL-7Ralpha, IL-15Ralpha, and cytokine-induced proliferative responses of T cells in a cohort of HIV-infected pediatric patients and adults classified on the basis of immunologic and virologic response to antiretroviral therapy were examined. The studies indicated that patients had increased percentages of effector memory CD8+ T cells in comparison to healthy volunteers. While patients with partially controlled viremia and poor CD4 T cell reconstitution manifested poor proliferative responses to anti-CD3 or HIV gag antigen stimulation, proliferative responses to Cgamma chain utilizing cytokines IL-2, IL-7, and IL-15 were robust. Another Cgamma chain utilizing cytokine, IL-21 had no influence on cellular proliferation but enhanced perforin expression in effector CD8 T cells. Thus, cytokine receptor deficiencies may contribute to immune deficiency in HIV-infected patients, and Cgamma chain cytokines may play an important role in vivo in immune homeostasis in lymphopenic patients by maintaining the memory subsets of T cells in patients with CD4 T cell deficiency.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917047     DOI: 10.1007/s12026-007-0036-9

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  63 in total

1.  Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children.

Authors:  S M Essajee; M Kim; C Gonzalez; M Rigaud; A Kaul; S Chandwani; W Hoover; R Lawrence; H Spiegel; H Pollack; K Krasinski; W Borkowsky
Journal:  AIDS       Date:  1999-12-24       Impact factor: 4.177

2.  Massive infection and loss of CD4+ T cells occurs in the intestinal tract of neonatal rhesus macaques in acute SIV infection.

Authors:  Xiaolei Wang; Terri Rasmussen; Bapi Pahar; Bhawna Poonia; Xavier Alvarez; Andrew A Lackner; Ronald S Veazey
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

3.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  The acquired immunodeficiency syndrome (AIDS): an update.

Authors:  A S Fauci; H C Lane
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

5.  Subcutaneous administration of interleukin-2 in human immunodeficiency virus type 1-infected persons.

Authors:  R T Davey; D G Chaitt; S C Piscitelli; M Wells; J A Kovacs; R E Walker; J Falloon; M A Polis; J A Metcalf; H Masur; G Fyfe; H C Lane
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

6.  Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

Authors:  J A Kovacs; M Baseler; R J Dewar; S Vogel; R T Davey; J Falloon; M A Polis; R E Walker; R Stevens; N P Salzman; Lane H. Clifford
Journal:  N Engl J Med       Date:  1995-03-02       Impact factor: 91.245

7.  Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection.

Authors:  Massimo Amicosante; Fabrizio Poccia; Cristiana Gioia; Carla Montesano; Simone Topino; Federico Martini; Pasquale Narciso; Leopoldo P Pucillo; Gianpiero D'Offizi
Journal:  J Infect Dis       Date:  2003-08-18       Impact factor: 5.226

8.  Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals.

Authors:  N Oyaizu; T W McCloskey; M Coronesi; N Chirmule; V S Kalyanaraman; S Pahwa
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

Review 9.  Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways.

Authors:  Panu E Kovanen; Warren J Leonard
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

10.  PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

Authors:  Constantinos Petrovas; Joseph P Casazza; Jason M Brenchley; David A Price; Emma Gostick; William C Adams; Melissa L Precopio; Timothy Schacker; Mario Roederer; Daniel C Douek; Richard A Koup
Journal:  J Exp Med       Date:  2006-09-05       Impact factor: 14.307

View more
  4 in total

1.  Rapid down-regulation of γc on T cells in early SIV infection correlates with impairment of T-cell function.

Authors:  Huanbin Xu; Xiaolei Wang; Bapi Pahar; Xavier Alvarez; Kelsi K Rasmussen; Andrew A Lackner; Ronald S Veazey
Journal:  FASEB J       Date:  2012-02-28       Impact factor: 5.191

Review 2.  Role of IL-21 and IL-21 receptor on B cells in HIV infection.

Authors:  Suresh Pallikkuth; Anita Parmigiani; Savita Pahwa
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

3.  CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals.

Authors:  Sunil K Ahuja; Hemant Kulkarni; Gabriel Catano; Brian K Agan; Jose F Camargo; Weijing He; Robert J O'Connell; Vincent C Marconi; Judith Delmar; Joseph Eron; Robert A Clark; Simon Frost; Jeffrey Martin; Seema S Ahuja; Steven G Deeks; Susan Little; Douglas Richman; Frederick M Hecht; Matthew J Dolan
Journal:  Nat Med       Date:  2008-03-30       Impact factor: 53.440

Review 4.  Interleukin-21 and T follicular helper cells in HIV infection: research focus and future perspectives.

Authors:  Suresh Pallikkuth; Savita Pahwa
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.